Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: long-term follow-up

A Shimoni; I Hardan; N Shem-Tov; R Yerushalmi; A Nagler

首页> 外文期刊>Leukemia >Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: long-term follow-up

【24h】

Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: long-term follow-up

机译：使用清髓和降低强度条件在AML和MDS中进行同种异体造血干细胞移植：长期随访

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Leukemia》 |2010年第5期|共3页
作者
A Shimoni; I Hardan; N Shem-Tov; R Yerushalmi; A Nagler;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity [J] . A Shimoni, I Hardan, N Shem-Tov, Leukemia . 2006,第2期

机译：使用清髓和降低强度的条件进行AML和MDS的同种异体造血干细胞移植：剂量强度的作用
2. Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: Long-term follow-up [J] . Bj?rkstrandB., IacobelliS., HegenbartU., Journal of Clinical Oncology . 2011,第22期

机译：骨髓瘤的串联自体/降低强度条件同种异体干细胞移植与自体移植：长期随访
3. Reduced-Intensity Conditioning Versus Myeloablative Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis of Randomized Trials [J] . Kamal Ahmad, Abu Zar Muhammad, Fazeel Hafiz Muhammad, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：对骨髓增生综合征患者同种异体造血细胞移植的减少强度调节与骨髓性调节症：随机试验的系统评价和荟萃分析
4. Circulating Tumor DNA Predicts Post-Allogeneic Hematopoietic Stem Cell Transplantation in AML and MDS [C] . Sousuke Nakamura International Molecular Medicine Tri-Conference. . 2019

机译：循环肿瘤DNA预测AML和MDS中的同种异体造血干细胞移植
5. Long-Term Bone Mineral Density Loss Following Autologous and Allogeneic Hematopoietic Cell Transplantation and Effectiveness of Bone Loss Therapies to Combat the Loss. [D] . Croudy, Christopher M. 2012

机译：自体和同种异体造血细胞移植后的长期骨矿物质密度损失以及抗击骨损失疗法的有效性。
6. Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemia [O] . Vishal Dhere, Scott Edelman, Edmund K. Waller, -1

机译：急性骨髓性白血病患者同种异体的白消安/ cytoxan调理与强度降低的氟达拉滨/美法仑调理在异基因造血干细胞移植中的应用
7. Allogeneic stem-cell transplantation in patients with AML and MDS using myeloablative versus reduced-intensity doses of intravenous busulfan (Busulfex): The role of dose intensity [O] . Shimoni A., Yeshurun M., Hardan I., 2005

机译：AML和MDS同种异体干细胞移植使用清髓性和降低剂量的静脉注射白消安（Busulfex）的剂量强度的作用

Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: long-term follow-up

著录项

相似文献

相关主题

期刊订阅